Webinar | Medical 3D Printing: Going From Why to How

Webinar | Medical 3D Printing: Going From Why to How

Fast-Track Manufacturing Projects with Industrial 3D Printing


Live Presentation – Tuesday June 9,  2015  •  2:00 PM ET

3D printing has been utilized in the medical industry for over 20 years. In recent years, the number of applications, utilization, and utility have increased exponentially. This increase has been driven by two key factors: (1) crossing the chasm from “how to print” to “why adopt 3D printing and additive manufacturing”, and (2) the dramatically increased selection of technologies and materials that meet the needs of medical professionals. 

In this Webinar you will: 

  1. Learn the History of medical adoption of 3D printing and additive manufacturing. 

  2. Create a taxonomy of the reasons why to adopt additive, and highlight innovations that are being conceived and brought to market by innovators, 3D printing companies, and customers that address unmet clinical need and economics of the delivery of healthcare. 

  3. See specific examples on how technology and material development is changing the medical industry and surgery planning.

​​Medical 3D Printing Webinar Register




Scott Rader Medical 3D printingR. Scott Rader, PhD.
GM, Medical Solutions
Stratasys Ltd.

Over the course of a 20+ year career in medical products, Scott brings to Stratasys the experience and expertise of matching clinical needs to technology solutions from the conceptual stage to the challenges of commercialization. 

Scott has a proven track record of developing and bringing to market a clinically diverse portfolio of successful and transformative medical devices. His experience spans the clinical domains of ophthalmology, hearing, otolaryngology, general and minimally invasive surgery, cancer, biomaterials, cardiovascular and orthopedics. Scott guided the commercial expansion of Bacchus Vascular (cardiovascular catheter combined with drug delivery) as the leading DVT interventional solution while CEO (acquired by Covidien), was CEO of two development stage companies (IlluminOss minimally invasive bone fracture fixation, Arsenal Medical bioabsorbable peripheral stent), as well as a founding team member or board member of three companies (two of which have been acquired by J&J and a Korean technology company). 

Before entering the industry, Scott was an assistant professor of both ophthalmology and engineering at Johns Hopkins University. He holds a Ph.D., M.S.E. and B.S.E. in mechanical engineering and materials science from Duke University.



Leave a Reply

Your email address will not be published. Required fields are marked *